RLACX
Price
$30.02
Change
-$0.09 (-0.30%)
Updated
Jul 31 closing price
Net Assets
975.36M
VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

RLACX vs VSMAX

RLACX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
RLACX vs. VSMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLACX is a Hold and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. RLACX (975M). VSMAX pays higher dividends than RLACX: VSMAX (1.21) vs RLACX (0.75). RLACX was incepted earlier than VSMAX: RLACX (18 years) vs VSMAX (26 years). RLACX (1.36) is less costly to investors than VSMAX (0.05). RLACX is a more actively managed with annual turnover of: 85.00 vs. VSMAX (17.00). RLACX has a lower initial minimum investment than VSMAX: RLACX (0) vs VSMAX (3000). RLACX annual gain was more profitable for investors over the last year : 25.35 vs. VSMAX (22.58). VSMAX return over 5 years is better than : 35.11 vs. RLACX (-17.94).
RLACXVSMAXRLACX / VSMAX
Total Expense Ratio1.360.052,720%
Annual Report Gross Expense Ratio1.360.052,720%
Fund Existence18 years26 years-
Gain YTD20.17614.588138%
Front Load6%N/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets975M189B1%
Annual Yield % from dividends0.751.2161%
Returns for 1 year25.3522.58112%
Returns for 3 years18.1543.4242%
Returns for 5 years-17.9435.11-51%
Returns for 10 years12.18155.968%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H